# Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma

> **NCT00974324** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 15 (estimated)

## Conditions studied

- T Cell Lymphoma

## Interventions

- **DRUG:** endostar and CHOP

## Key facts

- **NCT ID:** NCT00974324
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2010-09
- **Final completion:** 2011-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2010-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974324, "Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00974324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*